Changes in trial parameters
- PMID: 11214164
- DOI: 10.1016/S0140-6736(05)71764-5
Changes in trial parameters
Comment on
-
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.Lancet. 2000 Sep 16;356(9234):961-7. doi: 10.1016/s0140-6736(00)02712-4. Lancet. 2000. PMID: 11041396 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
